What does EDHM mean in UNCLASSIFIED
Eosinophilic Dermatosis of Hematologic Malignancy (EDHM) is a rare skin condition characterized by an abnormal number of eosinophils, a type of white blood cell, infiltrating the skin. It is often associated with an underlying hematologic malignancy, such as leukemia or lymphoma.
EDHM meaning in Unclassified in Miscellaneous
EDHM mostly used in an acronym Unclassified in Category Miscellaneous that means Eosinophilic Dermatosis of Hematologic Malignancy
Shorthand: EDHM,
Full Form: Eosinophilic Dermatosis of Hematologic Malignancy
For more information of "Eosinophilic Dermatosis of Hematologic Malignancy", see the section below.
Introduction to EDHM
Symptoms of EDHM
EDHM manifests with a variety of skin symptoms, including:
- Pruritic: Intense itching
- Erythematous: Reddened patches or plaques
- Urticarial: Hives
- Eczematous: Dry, scaly skin
- Bullous: Blisters
Causes of EDHM
The exact cause of EDHM is not fully understood, but it is believed to be related to the presence of an underlying hematologic malignancy. Eosinophils are a type of white blood cell that is involved in the body's immune response. In EDHM, these cells infiltrate the skin, leading to inflammation and the characteristic skin symptoms.
Diagnosis of EDHM
Diagnosing EDHM involves a combination of:
- Physical Examination: A dermatologist will examine the skin to assess the symptoms and rule out other skin conditions.
- Biopsy: A small sample of skin is removed and examined under a microscope to confirm the presence of eosinophils.
- Blood Tests: Blood tests are performed to check for an underlying hematologic malignancy.
Treatment of EDHM
The treatment of EDHM focuses on managing the underlying hematologic malignancy. This may involve chemotherapy, radiation therapy, or targeted therapy. The skin symptoms of EDHM may be treated with topical corticosteroids or antihistamines to reduce inflammation and itching.
Conclusion
EDHM is a rare but serious skin condition that is associated with an underlying hematologic malignancy. It is important to seek medical attention if you experience any unexplained skin symptoms, especially if you have a history of hematologic disorders. Early diagnosis and treatment can help manage the condition and improve the overall prognosis.
Essential Questions and Answers on Eosinophilic Dermatosis of Hematologic Malignancy in "MISCELLANEOUS»UNFILED"
What is EDHM?
Eosinophilic Dermatosis of Hematologic Malignancy (EDHM) is a rare skin condition that occurs in people with certain types of blood cancers. It is characterized by an eruption of eosinophils, a type of white blood cell, in the skin.
What causes EDHM?
The exact cause of EDHM is unknown, but it is believed to be triggered by the presence of a hematologic malignancy, which is a cancer of the blood or bone marrow. Certain types of leukemia and lymphoma are commonly associated with EDHM.
What are the symptoms of EDHM?
EDHM typically presents as a widespread rash that can be itchy, painful, or burning. The rash may be red, purple, or brown and can vary in appearance from small, raised bumps to large, swollen plaques. Other symptoms may include fever, fatigue, and swollen lymph nodes.
How is EDHM diagnosed?
EDHM is diagnosed based on a combination of physical examination, skin biopsy, and blood tests. The skin biopsy will show an accumulation of eosinophils in the skin. Blood tests may be done to check for underlying hematologic malignancies.
How is EDHM treated?
The treatment for EDHM involves managing the underlying hematologic malignancy. Chemotherapy, radiation therapy, or targeted therapies may be used to treat the cancer. Topical treatments, such as corticosteroids or calamine lotion, can help relieve the skin rash. In some cases, oral medications may be prescribed to suppress the immune system and reduce inflammation.
What is the prognosis for EDHM?
The prognosis for EDHM depends on the type and stage of the underlying hematologic malignancy. With effective management of the cancer, the skin rash associated with EDHM can improve or resolve completely. However, if the underlying cancer is not treated, EDHM may persist or worsen.